OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of de novo humanized and sequence-optimized single domain antibodies: a prospective case study
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Showing 8 citing articles:
Prospects for the computational humanization of antibodies and nanobodies
G. Gordon, Matthew I. J. Raybould, Chi Yan Wong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
G. Gordon, Matthew I. J. Raybould, Chi Yan Wong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library
Gihan S. Gunaratne, Joseph P. Gallant, Kendahl L. Ott, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Gihan S. Gunaratne, Joseph P. Gallant, Kendahl L. Ott, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Elena Alexander, Kam W. Leong
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Elena Alexander, Kam W. Leong
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Taming the beast: engineering strategies and biomedical potential of antibody-based cytokine mimetics
Lukas Pekar, Simon Krah, Stefan Zielonka
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 115-118
Open Access | Times Cited: 2
Lukas Pekar, Simon Krah, Stefan Zielonka
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 115-118
Open Access | Times Cited: 2
Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features
Paul Arras, Jasmin Zimmermann, Britta Lipinski, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 461-470
Open Access | Times Cited: 1
Paul Arras, Jasmin Zimmermann, Britta Lipinski, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 461-470
Open Access | Times Cited: 1
A comprehensive overview of recent advances in generative models for antibodies
Fanxu Meng, Na Zhou, Hu Guangchun, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2648-2660
Open Access | Times Cited: 1
Fanxu Meng, Na Zhou, Hu Guangchun, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2648-2660
Open Access | Times Cited: 1
Phage display technology and its impact in the discovery of novel protein-based drugs
Catherine J. Hutchings, Aaron K. Sato
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 887-915
Open Access
Catherine J. Hutchings, Aaron K. Sato
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 887-915
Open Access
Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects
Peter Slavny, Manjunath Hegde, Achim Doerner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Peter Slavny, Manjunath Hegde, Achim Doerner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
